Breast Cancer Invasive
Showing 1 - 18 of 18
Breast Cancer Invasive, Hormone-receptor-positive Breast Cancer, HER2 Low Breast Carcinoma Trial in Guangzhou (Pyrotinib,
Not yet recruiting
- Breast Cancer Invasive
- +3 more
- Pyrotinib, epirubicin or doxorubicin, cyclophosphamide, paclitaxel
- Placebo, epirubicin or doxorubicin, cyclophosphamide, paclitaxel
-
Guangzhou, Guangdong, ChinaSun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Nov 17, 2023
Breast Cancer, Breast Cancer Invasive Trial in Groningen (Fluorescence guided detection of tumor positive margins.)
Not yet recruiting
- Breast Cancer
- Breast Cancer Invasive
- Fluorescence guided detection of tumor positive margins.
-
Groningen, Netherlands
- +1 more
Jul 10, 2023
Early-Stage Triple Negative Breast Cancer Undergoing Neoadjuvant
Not yet recruiting
- Breast Cancer Triple Negative
- +3 more
-
Atlanta, GeorgiaEmory University/Winship Cancer Institute
May 18, 2023
Breast Cancer Invasive Trial in Seoul (Leuplin or zoladex)
Recruiting
- Breast Cancer Invasive
- Leuplin or zoladex
-
Seoul, Korea, Republic ofSeoul National University Hospital
Oct 16, 2022
Breast Cancer Invasive Trial (Breast surgery omission)
Not yet recruiting
- Breast Cancer Invasive
- Breast surgery omission
- (no location specified)
Aug 16, 2022
Breast Cancer Patients Trend Distinctive Regional
Completed
- Breast Cancer
- +4 more
-
Karachi, Sindh, PakistanSindh Institute of Urology and Transplantation
Jul 18, 2022
Breast Cancer, Breast Cancer Invasive, Breast Cancer in Situ Trial in Ghent (high-resolution PET-CT specimen imaging.)
Recruiting
- Breast Cancer
- +2 more
- high-resolution PET-CT specimen imaging.
-
Ghent, Vlaanderen, Belgium
- +1 more
Jul 11, 2022
Breast Cancer Invasive, Prostate Cancer Trial in New York (Audiovisual Intervention- Radiation Therapy Education, ASTRO
Recruiting
- Breast Cancer Invasive
- Prostate Cancer
- Audiovisual Intervention- Radiation Therapy Education
- +3 more
-
New York, New YorkColumbia University Irving Medical Center
May 10, 2022
Breast Cancer Invasive Trial in Bordeaux, Toulouse (Patients with invasive breast cancer will receive:)
Recruiting
- Breast Cancer Invasive
- Patients with invasive breast cancer will receive:
-
Bordeaux, France
- +1 more
Mar 29, 2022
Breast Cancer Invasive, Metastatic Cancer, Oligoprogressive Trial in Amsterdam (procedure, radiation, other)
Not yet recruiting
- Breast Cancer Invasive
- +2 more
- Surgery
- +2 more
-
Amsterdam, NetherlandsAntoni van Leeuwenhoek
Mar 21, 2022
Breast Cancer Invasive Trial in Shanghai (Pyrotinib, Trastuzumab, Pertuzumab)
Active, not recruiting
- Breast Cancer Invasive
- Pyrotinib
- +7 more
-
Shanghai, Shanghai, ChinaRuijin Hospital, Shanghai Jiaotong University School of Medicine
Mar 28, 2022
Interleukin-7 Serum Level as Biological Marker in Breast Cancer
Completed
- Breast Cancer Invasive
-
Pristina, KosovoFaton I. Sermaxhaj, MD
Mar 18, 2022
Breast Cancer Invasive Trial (Intervention group on diet and physical activity, Control group: only public recommendation an
Completed
- Breast Cancer Invasive
- Intervention group on diet and physical activity
- Control group: only public recommendation an lifestyle
- (no location specified)
Aug 20, 2021
Breast Cancer, Breast Cancer Invasive Trial (Mastectomy)
Completed
- Breast Cancer
- Breast Cancer Invasive
- Mastectomy
- (no location specified)
Jan 28, 2021
No Axillary Surgery for Early Breast Cancer.
Completed
- Breast Cancer Invasive
- Omitting axillary surgery in early breast cancer
- (no location specified)
Sep 12, 2018